targeted-therapy

Documents about targeted-therapy

• Systemic treatment of advanced biliary tract cancers: moving from ‘all-comers’ to precision medicine#482584HAL (France)
• Hepatocellular Carcinoma#486867Directory of Open Access Books
• TACE and/or HAIC Combined With Molecular-targeted Therapy and Immunotherapy for HCC#880913ClinicalTrials.gov
• Efficacy of Targeted Medical Therapy in Angina and Nonobstructive Coronary Arteries#907864ClinicalTrials.gov
• Ivosidenib Plus mFOLFOXIRI and Celecoxib for BRAF-targeted Therapy-refractory BRAF V600E-mutant Colorectal Cancer Patients#1033043ClinicalTrials.gov
• Neoadjuvant Endocrine Therapy in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Node-Negative Breast Cancer#824836ClinicalTrials.gov
• Survival impact of [²²⁵Ac]Ac-DOTATOC alpha-therapy in a preclinical model of pancreatic neuroendocrine tumor liver micrometastases#156016HAL (France)
• Dasatinib as Therapy for Myeloproliferative Disorders (MPDs)#841115ClinicalTrials.gov
• Downstaging Protocol Containing Immunotherapy for HCC Beyond the Milan Criteria Before Liver Transplantation#867957ClinicalTrials.gov
• The role of copper and cuproptosis in digestive system cancers: novel therapeutic strategies and mechanistic insights#4551Europe PMC
• Infection-targeted innovations in anastomotic leak management: endoscopic advances, antimicrobial biomaterials, and precision strategies#4709Europe PMC
• Real-world costs per life-year of targeted therapy, incidence, lifetime health impact, and medical costs of renal cell carcinoma in Taiwan.#146040NCBI PubMed Central
• Decoding the microbiome: artificial intelligence-targeted gut microenvironment breakthroughs in personalized cancer therapy.#244567PubMed
• Combination therapy with a novel CD2-targeted costimulatory bispecific antibody overcomes limitations of CD3 T cell engager treatment for solid tumors.#285110NCBI PubMed Central
• Immunological heterogeneity in rheumatoid arthritis: challenges in early-stage stratification, non-response to targeted therapy, and the restoration of immune tolerance.#427725NCBI PubMed Central
• AI-Based Multimodal Integration for Tumor Microenvironment Analysis and Response Prediction in HCC Treated With TACE Plus Immunotherapy and Targeted Therapy (CHANCE2601)#802625ClinicalTrials.gov
• Probiotics Combined With Standard Chemotherapy Plus Targeted Therapy in Patients With Metastatic Colorectal Cancer#825341ClinicalTrials.gov
• Molecular Analysis and Treatment Options of Thymic Malignancies#849753ClinicalTrials.gov
• A Clinical Research About CD70-targeted CAR-NKT Cells Therapy in Subjects with Advanced Malignant Solid Tumors#850110ClinicalTrials.gov
• Cognitive Behavioral Intervention for Targeted Therapy Fatigue (CBT-TTF) Intervention#856258ClinicalTrials.gov
• Value of Biological Age, in Addition to Individual Frailty, for Personalising the Management of Cancer Treated with Targeted Therapy#876136ClinicalTrials.gov
• Spanish Retrospective Study to Evaluate the Efficacy and Safety of Targeted Therapies After Pazopanib as First-line Therapy#981129ClinicalTrials.gov
• Safety and efficacy of pralsetinib in RET fusion–positive non-small-cell lung cancer including as first-line therapy: update from the ARROW trial#274667IRIS
• Somatostatin-Receptors (SSTR)-Agonist [212Pb]VMT-alpha-NET in Metastatic or Inoperable SSTR+ Gastrointestinal Neuroendocrine Tumor and Pheochromocytoma/Paraganglioma Previously Treated With Systemic Targeted Radioligand Therapy#901148ClinicalTrials.gov
• A prostate-specific membrane antigen targeted small molecule-drug conjugate for efficient prostate cancer therapy at a low dosage#5310Europe PMC
• Allogeneic Gamma-delta T Cells Combined With Targeted Therapy and Immunotherapy in a Phase 1 Clinical Trial for First-line Treatment of Hepatocellular Carcinoma#426784ClinicalTrials.gov
• Editorial Perspective: Connecting Transdiagnostic Mechanisms Targeted in Cognitive Behavioral Therapies with Empirically-Based Symptom Dimensions#434964OSF
• To Observe the CD7-targeted CAR-T Therapy in the Treatment of MRD Positive T-ALL/LBL Post Allo-HSCT#435750ClinicalTrials.gov
• Clinical Outcomes Following Personalized Gut Microbiota-Targeted Therapy in Children with Atopic Dermatitis and Laboratory-Confirmed Dysbiosis: A Single-Arm Prospective Pilot Study.#455309NCBI PubMed Central
• Study to Determine Safety, Pharmacokinetics, Pharmacodynamics of BAY73-4506 in Combination With mFOLFOX6 or FOLFIRI#831909ClinicalTrials.gov
• Identification of Specific Molecular Signatures in Pediatric, Adolescent, and Young Adult Rhabdomyosarcoma Through Spatial Proteome Analysis Using Mass Spectrometry#842353ClinicalTrials.gov
• Evaluation of Targeted Radionuclide Therapy of Lu-177 PSMA in Patients With Compromised Renal and/or Bone Marrow Function#858707ClinicalTrials.gov
• The Effectiveness of Using Preventive Multimedia Teaching Program in Lung Cancer Women Receiving Targeted Therapy on Skin-Related Quality of Life#901002ClinicalTrials.gov
• Real-life Pharmacological Monitoring of Encorafenib-Binimetinib in the Treatment of Metastatic Melanoma#901861ClinicalTrials.gov
• Nimotuzumab Combined With Radiotherapy for Older Patients With Esophageal Cancer: a Single, Non-control Clinical Trial#913848ClinicalTrials.gov
• Ipilimumab N01 Plus Sintilimab and Lenvatinib as First-line Therapy for Locally Advanced or Metastatic TFE3-Rearranged Renal Cell Carcinoma: A Prospective, Multicenter, Single-Arm, Phase II Clinical Trial#432896ClinicalTrials.gov
• Optimization of Individualized Therapy for CRCs With Secondary RESISTance Towards Anti-EGFR Targeted Therapy Using an Avatar Model#801999ClinicalTrials.gov
• Infection-targeted innovations in anastomotic leak management: endoscopic advances, antimicrobial biomaterials, and precision strategies.#9729PubMed
• TGF-β Receptor Inhibitor SB431542 Enhanced the Sensitivity of Gastric Cancer to 5-Fluorouracil: New Combined Targeted Therapy#274720IRIS
• Baseline and early 18F-FDG PET/CT evaluations as predictors of progression-free survival in metastatic breast cancer patients treated with targeted anti-CDK therapy#676820HAL (France)
• Poziotinib in Stage IV Lung Adenocarcinoma With HER2 Mutation (KASTT001)#802082ClinicalTrials.gov
• The Prognostic Impact of HER2 Expression in Non-Metastatic HER2-Positive Breast Cancer Treated With Dual HER2-Targeted Therapy#874621ClinicalTrials.gov
• The Effect of Cognition Targeted Physical Therapy in People With Non-specific Neck Pain#884033ClinicalTrials.gov
• Fruquintinib Combined With Sintilimab ± Radiotherapy for Third-line Treatment of Colorectal Cancer With Liver Metastases#896818ClinicalTrials.gov
• A Study of BMS-986012 in Combination With Carboplatin, Etoposide, and Nivolumab as First-line Therapy in Extensive-stage Small Cell Lung Cancer#865729ClinicalTrials.gov
• Application and mechanistic research of novel therapeutic strategies in cisplatin-resistant small cell lung cancer#4521Europe PMC
• The Structure, Pathogenesis, and Inhibition of the p53-MDM2 Pathway#277879Scholar Commons
• CFTR modulator response in nasal organoids derived from people with cystic fibrosis#288364IRIS
• ETIOPATHOGENESIS, MODERN DIAGNOSTICS, AND TREATMENT METHODS OF ABNORMAL UTERINE BLEEDING#299525Zenodo (CERN)
• The potential of targeted IL-4 therapy for the comorbidity of atopic dermatitis and attention-deficit/hyperactivity disorder in children via the skin-brain axis.#402458NCBI PubMed Central